ERBB2 and breast carcinoma: However, this relationship was not assessed in this study, and further studies designed to unravel the association between CD2 expression and anti-HER2 antibody response or the value of CD2 in predicting anti-HER2 antibody response in HER2+ breast cancer will be required.